Objective: To identify the fears and concerns regarding HCV amongst people presenting to a free screening camp and to identify the barriers preventing patients from linkage to care (seeking medical care for HCV). Study Design: Cross Sectional study. Setting: Gajrakh District, Gujranwala. Period: 15th February to 14th March 2019. Material & Methods: Questionnaire was filled by all the participants attending free screening and treatment camp. Questionnaire explored socio-demographic features, financial status, knowledge regarding awareness of disease e.g. risk factors for transmission of disease, possible complications of disease, fears regarding diagnosis &treatment of HCV and possible concerns of female population. Results: This study included 100 participants, 58% were females and 42% were males with a mean age of 46.23±12.36. Fifty seven percent of the participants were laborer, 15 were salary based, 6 were shopkeepers and 7 were housewives. Majority of participants have a sound knowledge about transmission of HCV i.e 95% said yes to the question about spread via ear/nose piercing by unsterilized needles, however, 49% and 61% think that hugging the patient and eating and drinking with patient also caused viral spread respectively. Most important factors contributing to inability to start treatment were inability to bear cost, missing of daily wages, lack of transport, fear of side effects and fear of being outcast in 75, 66, 41, 26 and 25% respectively. Conclusion: Socioeconomic factors like costly treatment, missing of daily wages, lack of transport, fear of side effects and being outcast are real hindrance in getting HCV treatment.
Liver disorders during pregnancy may have a strong bearing on both mother andthe foetus. Acute Hepatitis E is rightly considered to be an emerging infection. Loco-regionalstudies have shown it to be the most common cause of Acute Hepatitis in pregnant females. Wecarried out our study to elaborate the demographic profile of pregnant females presenting withAcute Hepatitis E along with the fetomaternal outcomes. Study Design: It was a prospective,observational study. Intervention: None. Settings and Participants: Over a period of two years,73 pregnant patients were evaluated by our team in the Department of Gastroenterology forsuspicion of liver disease. Outcomes and Measurement: Data was evaluated for quantitativeand qualitative variables. Outcome of mother, pregnancy and neonates was also recordedwhere available. Results: During the study period 73 pregnant patients presented with liverdisease giving an incidence of 3.6%. Serological evidence of Acute Hepatitis E was found in 50(68.5%) of the patients. Fulminant hepatic Failure developed in 5 (10%) patients. All five patientswith FHF could not survive. There were 4 (8%) intra-uterine deaths, 1 (2%) abortion and 5 (10%)neonatal deaths. Shortcomings: Relatively small sample size. Conclusions: Acute hepatitis Eduring pregnancy predicts poor outcomes for the mothers, foetus and neonates
Liver disorders during pregnancy may have a strong bearing on both mother and the foetus. Acute Hepatitis E is rightly considered to be an emerging infection. Loco-regional studies have shown it to be the most common cause of Acute Hepatitis in pregnant females. We carried out our study to elaborate the demographic profile of pregnant females presenting with Acute Hepatitis E along with the fetomaternal outcomes. Study Design: It was a prospective, observational study. Intervention: None. Settings and Participants: Over a period of two years, 73 pregnant patients were evaluated by our team in the Department of Gastroenterology for suspicion of liver disease. Outcomes and Measurement: Data was evaluated for quantitative and qualitative variables. Outcome of mother, pregnancy and neonates was also recorded where available. Results: During the study period 73 pregnant patients presented with liver disease giving an incidence of 3.6%. Serological evidence of Acute Hepatitis E was found in 50 (68.5%) of the patients. Fulminant hepatic Failure developed in 5 (10%) patients. All five patients with FHF could not survive. There were 4 (8%) intra-uterine deaths, 1 (2%) abortion and 5 (10%) neonatal deaths. Shortcomings: Relatively small sample size. Conclusions: Acute hepatitis E during pregnancy predicts poor outcomes for the mothers, foetus and neonates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.